Search
Search Results
##search.searchResults.foundPlural##
-
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3611PDF: 1470HTML: 2735 -
BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
3407PDF: 1955HTML: 3719 -
EPIDEMIOLOGY OF INVASIVE FUNGAL INFECTIONS IN THE MEDITERRANEAN AREA
2361PDF: 1068HTML: 4993 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4219PDF: 1329HTML: 2127Table 1: 238 -
Magnusiomyces capitatus Breakthrough Infection in Allogeneic Hematopoietic Cell Transplant Recipients Receiving Echinocandin Prophylaxis: Clinical Features, Management, and Review of the Literature
110PDF: 199Suppl. Files: 34Html: 117Html Suppl. Files: 94 -
CHILDREN IN CORONAVIRUSES’ WONDERLAND: WHAT CLINICIANS NEED TO KNOW Corona virus and Children
1596PDF: 1037HTML: 521 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
3152PDF: 1096HTML: 3041 -
SPHINGOMONAS PAUCIMOBILIS INFECTIONS IN CHILDREN: NOSOCOMIAL VERSUS COMMUNITY ACQUIRED INFECTIONS
1912PDF: 1082HTML: 2088cover: 226Table 1. Co-morbidities associated with Sphingomonas paucimobilis infections.: 237Figure 1. The antimicrobial susceptibility patterns of Sphingomonas paucimobilis isolated from clinical specimens: 1854title page: 232 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4543PDF: 993HTML: 1370Table1: 261 -
-
WHAT ARE FUNGAL INFECTIONS?
4416PDF: 2513HTML: 27711de Pauw: 296 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4954PDF: 1634HTML: 2278Untitled: 278Untitled: 298Untitled: 315Untitled: 268Untitled: 279 -
NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria
2276PDF: 1182HTML: 10765Untitled: 243 -
INVASIVE CANDIDIASIS IN NON-HEMATOLOGICAL PATIENTS.
2459PDF: 1028HTML: 11174 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5539PDF: 1422HTML: 2884Cover letter: 250 -
THE EMERGING RESISTANCE IN NOSOCOMIAL URINARY TRACT INFECTIONS: FROM THE PEDIATRICS PERSPECTIVE.
2218PDF: 1028HTML: 267The emerging resistance in nosocomial urinary tract infections: from the pediatrics perspective: 284 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2465PDF: 799HTML: 2157Untitled: 280Untitled: 200Untitled: 231Untitled: 212Untitled: 226Untitled: 248Untitled: 235 -
-
-
IMPACT OF QUALITATIVE AND QUANTITATIVE IMMUNOPARESIS ON EARLY INFECTION RISK IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA Immunoparesis and early infection risk in myeloma
250PDF: 771HTML: 77 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3869PDF: 1348HTML: 3957Untitled: 287Untitled: 319 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1819PDF: 860HTML: 926jdoe, table 2 infections CML .doc: 253jdoe, table 1 infections CML .doc: 233 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2668PDF: 1270HTML: 1095 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2280PDF: 1081HTML: 4110Cover Letter: 273Figure 1: 280Figure 2: 272Table 1: 257 -
UPDATE ON THE LABORATORY DIAGNOSIS OF INVASIVE FUNGAL INFECTIONS
2579PDF: 1525HTML: 2033 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4468PDF: 1461HTML: 2208 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1947PDF: 811HTML: 580







